Merck, Otsuka Make R&D Pact for Buzzed-About Cancer Target

(Bloomberg) -- Merck & Co. will pay $50 million, plus as much as $2.5 billion in potential future payments, in a research and development deal with Otsuka Pharmaceutical Co. that includes a much-ta...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.